These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

628 related items for PubMed ID: 24385208

  • 1. Low prognostic implication of fibroblast growth factor family activation in triple-negative breast cancer subsets.
    Lee HJ, Seo AN, Park SY, Kim JY, Park JY, Yu JH, Ahn JH, Gong G.
    Ann Surg Oncol; 2014 May; 21(5):1561-8. PubMed ID: 24385208
    [Abstract] [Full Text] [Related]

  • 2. Androgen receptor expression predicts decreased survival in early stage triple-negative breast cancer.
    Choi JE, Kang SH, Lee SJ, Bae YK.
    Ann Surg Oncol; 2015 Jan; 22(1):82-9. PubMed ID: 25145503
    [Abstract] [Full Text] [Related]

  • 3. Expression of FGFR1 is an independent prognostic factor in triple-negative breast cancer.
    Cheng CL, Thike AA, Tan SY, Chua PJ, Bay BH, Tan PH.
    Breast Cancer Res Treat; 2015 May; 151(1):99-111. PubMed ID: 25868865
    [Abstract] [Full Text] [Related]

  • 4. Clinicopathological characteristics of triple negative breast cancer at a tertiary care hospital in India.
    Dogra A, Doval DC, Sardana M, Chedi SK, Mehta A.
    Asian Pac J Cancer Prev; 2014 May; 15(24):10577-83. PubMed ID: 25605142
    [Abstract] [Full Text] [Related]

  • 5. Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer.
    André F, Bachelot T, Campone M, Dalenc F, Perez-Garcia JM, Hurvitz SA, Turner N, Rugo H, Smith JW, Deudon S, Shi M, Zhang Y, Kay A, Porta DG, Yovine A, Baselga J.
    Clin Cancer Res; 2013 Jul 01; 19(13):3693-702. PubMed ID: 23658459
    [Abstract] [Full Text] [Related]

  • 6. The fibroblast growth factor receptor 1 (FGFR1), a marker of response to chemoradiotherapy in breast cancer?
    Massabeau C, Sigal-Zafrani B, Belin L, Savignoni A, Richardson M, Kirova YM, Cohen-Jonathan-Moyal E, Mégnin-Chanet F, Hall J, Fourquet A.
    Breast Cancer Res Treat; 2012 Jul 01; 134(1):259-66. PubMed ID: 22438050
    [Abstract] [Full Text] [Related]

  • 7. Increased expression of fibroblastic growth factor receptor 2 is correlated with poor prognosis in patients with breast cancer.
    Sun S, Jiang Y, Zhang G, Song H, Zhang X, Zhang Y, Liang X, Sun Q, Pang D.
    J Surg Oncol; 2012 Jun 15; 105(8):773-9. PubMed ID: 22006548
    [Abstract] [Full Text] [Related]

  • 8. Protein expression, gene amplification, and mutational analysis of EGFR in triple-negative breast cancer.
    Nakajima H, Ishikawa Y, Furuya M, Sano T, Ohno Y, Horiguchi J, Oyama T.
    Breast Cancer; 2014 Jan 15; 21(1):66-74. PubMed ID: 22481575
    [Abstract] [Full Text] [Related]

  • 9. Increased gene copy number of HER2 and concordant protein overexpression found in a subset of eyelid sebaceous gland carcinoma indicate HER2 as a potential therapeutic target.
    Lee MJ, Kim N, Choung HK, Choe JY, Khwarg SI, Kim JE.
    J Cancer Res Clin Oncol; 2016 Jan 15; 142(1):125-33. PubMed ID: 26141290
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of fibroblast growth factor receptors FGFR1 and FGFR2 in renal cell carcinoma.
    Tsimafeyeu I, Demidov L, Stepanova E, Wynn N, Ta H.
    Scand J Urol Nephrol; 2011 Apr 15; 45(3):190-5. PubMed ID: 21329481
    [Abstract] [Full Text] [Related]

  • 11. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer.
    Kim HR, Kim DJ, Kang DR, Lee JG, Lim SM, Lee CY, Rha SY, Bae MK, Lee YJ, Kim SH, Ha SJ, Soo RA, Chung KY, Kim JH, Lee JH, Shim HS, Cho BC.
    J Clin Oncol; 2013 Feb 20; 31(6):731-7. PubMed ID: 23182986
    [Abstract] [Full Text] [Related]

  • 12. Fibroblast growth factor receptor 1 gene amplification in pancreatic ductal adenocarcinoma.
    Lehnen NC, von Mässenhausen A, Kalthoff H, Zhou H, Glowka T, Schütte U, Höller T, Riesner K, Boehm D, Merkelbach-Bruse S, Kirfel J, Perner S, Gütgemann I.
    Histopathology; 2013 Aug 20; 63(2):157-66. PubMed ID: 23808822
    [Abstract] [Full Text] [Related]

  • 13. Fibroblast growth factor receptor (FGFR) gene amplifications are rare events in bladder cancer.
    Fischbach A, Rogler A, Erber R, Stoehr R, Poulsom R, Heidenreich A, Schneevoigt BS, Hauke S, Hartmann A, Knuechel R, Veeck J, Gaisa NT.
    Histopathology; 2015 Apr 20; 66(5):639-49. PubMed ID: 24898159
    [Abstract] [Full Text] [Related]

  • 14. Interactions between FGFR2 and RSK2-implications for breast cancer prognosis.
    Czaplinska D, Mieczkowski K, Supernat A, Skladanowski AC, Kordek R, Biernat W, Zaczek AJ, Romanska HM, Sadej R.
    Tumour Biol; 2016 Oct 20; 37(10):13721-13731. PubMed ID: 27476168
    [Abstract] [Full Text] [Related]

  • 15. Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt.
    Bahnassy A, Mohanad M, Ismail MF, Shaarawy S, El-Bastawisy A, Zekri AR.
    Exp Mol Pathol; 2015 Oct 20; 99(2):303-11. PubMed ID: 26232605
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of Fibroblast Growth Factor Receptor 2 Expression, Heterogeneity and Clinical Significance in Gastric Cancer.
    Han N, Kim MA, Lee HS, Kim WH.
    Pathobiology; 2015 Oct 20; 82(6):269-79. PubMed ID: 26516773
    [Abstract] [Full Text] [Related]

  • 17. Basal-like breast cancer defined by FOXC1 expression offers superior prognostic value: a retrospective immunohistochemical study.
    Ray PS, Bagaria SP, Wang J, Shamonki JM, Ye X, Sim MS, Steen S, Qu Y, Cui X, Giuliano AE.
    Ann Surg Oncol; 2011 Dec 20; 18(13):3839-47. PubMed ID: 21424368
    [Abstract] [Full Text] [Related]

  • 18. FGFR1 is an adverse outcome indicator for luminal A breast cancers.
    Shi YJ, Tsang JY, Ni YB, Chan SK, Chan KF, Tse GM.
    Oncotarget; 2016 Jan 26; 7(4):5063-73. PubMed ID: 26673008
    [Abstract] [Full Text] [Related]

  • 19. Fibroblast growth factor-2 and its receptor expression in proliferating precursor cells of the subventricular zone in the adult rat brain.
    Frinchi M, Bonomo A, Trovato-Salinaro A, Condorelli DF, Fuxe K, Spampinato MG, Mudò G.
    Neurosci Lett; 2008 Dec 05; 447(1):20-5. PubMed ID: 18835325
    [Abstract] [Full Text] [Related]

  • 20. Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries.
    Hughes SE.
    Cardiovasc Res; 1996 Sep 05; 32(3):557-69. PubMed ID: 8881516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.